Patterson Matthew R

CIK 00014010185 companiesCRANBURY, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001401018

Recent Transactions

50 trades

Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2025-05-22+30,000→ 30,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2024-05-23+30,000→ 30,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2023-06-14+23,000→ 23,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2023-05-26+30,000→ 30,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2022-06-15+18,000→ 18,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2022-06-14+16,911→ 16,911 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2021-06-17+18,000→ 18,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2021-02-05+16,900→ 16,900 total
Other
5:01 Acquisition Corp.
Class B Common Stock
2020-10-16+30,000→ 30,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2020-06-10+18,000→ 18,000 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−171,814→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−225,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−143,569→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−188,334→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−177,450→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−261,458→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−11,666→ 188,334 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−11,824→ 143,569 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$2.19/sh+74,297→ 237,968 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$0.78/sh+64,751→ 163,671 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−64,751→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−74,297→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$9.50/sh+11,824→ 249,792 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$15.26/sh+11,666→ 261,458 total
Gift
Audentes Therapeutics, Inc.
Common Stock
2019-12-26−12,500→ 98,920 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-05$59.21/sh−1,974→ 111,420 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-11-08$30.00/sh−14,426→ 113,394 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-11-08−14,426→ 155,393 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-11-08$9.50/sh+14,426→ 127,820 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-09-05$31.02/sh−1,974→ 113,394 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-08-12−20,000→ 169,819 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-08-12$34.02/sh−19,000→ 116,368 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-08-12$9.50/sh+20,000→ 135,368 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-08-12$34.52/sh−1,000→ 115,368 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2019-06-06+15,580→ 15,580 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-06-05$37.31/sh−3,332→ 115,368 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-25−17,000→ 64,751 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$0.78/sh+17,000→ 135,700 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$2.19/sh+4,000→ 122,700 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-25−4,000→ 74,297 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$30.00/sh−17,000→ 118,700 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$30.00/sh−4,000→ 118,700 total
Award
Audentes Therapeutics, Inc.
Common Stock
2019-02-06+63,700→ 118,700 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+177,450→ 177,450 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-12-06−40,000→ 31,702 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-12-06$0.78/sh+40,000→ 55,000 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.78/sh+2,144→ 17,144 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$39.13/sh−2,144→ 15,000 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$38.58/sh−5,448→ 15,000 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$38.04/sh−5,330→ 15,000 total

Companies

Recent Filings

Address

C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE

CRANBURY, NJ, 08512

View on SEC.gov